Consistent with this, CCL2 has been found to be one of the most strongly downregulated genes in endothelial cells of invasive breast cancer compared to endothelial cells of normal mammary vasculature (Parker et al., 2004). This evidence concerns the gene CCL2 and invasive breast carcinoma.